CD200 and neoplasm: In addition, it has been demonstrated that tumor cell increased the expression of CD200 in ECs, which in combination with its ligand, CD200R (present in macrophages and DCs), might be a mechanism leading to immunosuppression in the TME (Belkin et al., 2013; Figure 1A).